Its just a case of no one knows about it and has run the numbers. But given its so close to transition from 60K cases to 1.2m cases and has already produced a rediculously good profit upgrade. It will get noticed now.
Its likely to bounce around now but the real cash will be in Q3, Q4 and Q1 Q2 of 2011 as compounding results from 1.2M cases per annum filter through. Thats in theory 20 x current earnings on a $10m mcap company. Theoretically it coul db e earnings of up to $40M. More likely to be around $30+ due to teething, marketing and sales issues. On that basis and a PE of just 8 your looking at a $240M company approx. DYOR. These numbers are no cross checked , may be innacurate. Seek expert advice etc.
I provide this so you can investigate. Do not use this to make a decision.
excellent report. , page-7
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
